Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in britain

Cancer Research

Volumn 48, Issue 10, 1988, Pages 2929-2932

  Clare Pippard, E ^a   Hall, Andrew J ^a   Barker, David J P ^a   Bridges, Bryn A ^b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIA TELANGIECTASIA; CANCER MORTALITY; EPIDEMIOLOGY; FAMILIAL CANCER; HEREDITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; UNITED KINGDOM; XERODERMA PIGMENTOSUM;

ADOLESCENT; ADULT; AGED; ATAXIA TELANGIECTASIA; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MIDDLE AGE; NEOPLASMS; RISK; XERODERMA PIGMENTOSUM;

EID: 0023913739     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bridges, B. A., and Harnden, D. G. (eds.), Ataxia-Telangiectasia: A Cellular and Molecular Link between Cancer, Neuropathology and Immune Deficiency. Chichester: John Wiley, 1982.
2. Gatti, R. A., and Swift, M. (eds.), Ataxia-Telangiectasia: Genetics, Neuropathology and Immunology of a Degenerative Disease of Childhood. New York: Alan R. Liss, 1985.
3. Kraemer, K. H., Lee, M. M., and Scotto, J. Xeroderma pigmentosum. Cutaneous, ocular and neurologic abnormalities in 830 published cases. Arch. Dermatol., 123: 241-250, 1987.
4. Morrell, D., Cromartie, E., and Swift, M. Mortality and cancer incidence in 263 patients with ataxia-telangiectasia. J. Natl. Cancer Inst., 77: 89-92, 1986.
5. Kraemer, K. H. Lee, M. M., and Scotto, J. DNA repair protects against cutaneous and internal neoplasm: Evidence from xeroderma pigmentosum. Carcinogenesis (Lond.), 5: 511-514, 1984.
6. Swift, M., Sholman, L., Perry, M., and Chase, C. Malignant neoplasms in the families of patients with ataxia-telangiectasia. Cancer Res., 36: 209-215, 1976.
7. Swift, M. Genetics and epidemiology of ataxia-telangiectasia. In: R. A. Gatti and M. Swift (eds.), Ataxia-Telangiectasia: Genetics, Neuropathology and Immunology of a Degenerative Disease of Childhood, pp. 133-146. New York: Alan R. Liss, 1985.
8. Swift, M., and Chase, C. Cancer in families with xeroderma pigmentosum. J. Natl. Cancer Inst., 62: 1415-1421, 1979.
9. Oxford, J. M., Harnden, D. G., Parrington, J. M., and Delhanty, J. D. A. Specific chromosome aberrations in ataxia-telangiectasia. J. Med. Genet., 12: 251-262, 1975.
10. Chen, P. C., Lavin, M. F., Kidson, C., and Moss, D. Identification of ataxiatelangiectasia heterozygotes, a cancer prone population. Nature (Lond.), 274: 484-486, 1978.
11. Paterson, M. C., Anderson, A. K., Smith, B. P., and Smith, P. J. Enhanced radiosensitivity of cultured fibroblasts from ataxia-telangiectasia heterozygotes manifested by defective colony-forming ability and reduced DNA repair replication after hypoxic gamma-irradiation. Cancer Res., 39: 3725-3734, 1979.
12. Paterson, M. C., MacFarlane, S. J., Gentner, N. E., and Smith, B. P. Cellular hypersensitivity to chronic gamma-radiation in cultured fibroblasts from ataxia-telangiectasia heterozygotes.In: R. A. Gatti and M. Swift (eds.), Ataxia-Telangiectasia: Genetics, Neuropathology and Immunology of a Degenerative Disease of Childhood, pp. 73-87. New York: Alan R. Liss, 1985.
13. Kidson, C., Chen, P., and Imray, P. Ataxia-telangiectasia heterozygotes: Dominant expression of ionizing radiation sensitive mutants. In: B. A. Bridges and D. G. Harnden (eds.), Ataxia-Telangiectasia: A Cellular and Molecular Link between Cancer, Neuropathology and Immune Deficiency, pp. 363-372. Chichester: John Wiley, 1982.
14. Shiloh, Y., Tabor, E., and Becker, Y. The response of ataxia-telangiectasia homozygous and heterozygous skin fibroblasts to neocarzinostatin. Carcinogenesis (Lond.), J: 815-820, 1982.
15. Arieti, C. F., and Priestley, A. An assessment of the radiosensitivity of ataxiatelangiectasia heterozygotes.In: R. A. Gatti and M. Swift (eds.), AtaxiaTelangiectasia: Genetics, Neuropathology and Immunology of a Degenerative Disease of Childhood, pp. 101-109. New York: Alan R. Liss, 1985.
16. Bridges, B. A., Lenoir, G., and Tomatis, L. Workshop on ataxia-telangiectasia heterozygotesand cancer. Cancer Res., 45: 3979-3980, 1985.
17. Kraemer, K. H. Oculo cutaneous and internal neoplasms in xeroderma pigmentosum: Implications for theories of Carcinogenesis. In: B. Pullman, P. O. P. Tso, and H. Gelboin (eds.), Carcinogenesis: Fundamental Mechanisms and Environmental Effects. D. Reidel Publishing Co., 1980.
18. Cairns, J. The origin of human cancers. Nature (Lond.), 289: 353-357, 1981.
19. World Health Organization: International Classification of Diseases, 9th revision. Geneva: WHO, 1977.
20. Hill, I. D. Computing man-years at risk. Br. J. Prev. Soc. Med., 26: 132-134, 1972.
21. Sedgwick, R. P., and Boder, E. Ataxia-telangiectasia. In: P. J. Vinken and G. W. Bruyn (eds.), Handbook of Clinical Neurology, Vol. 14, pp. 267-339. Amsterdam: North-Holland, 1972.
22. Swift, M., Morrell, D., Cromartie, E., Chamberlain. A. R., Skolnick, M. H., and Bishop, D. T. The incidence and gene frequency of ataxia-telangiectasia in the United States. Am. J. Hum. Genet., 39: 573-583, 1986.
23. Spector, B. D., Filipovich, A. H., Perry, G. S., III, and Kersey, J. H. Epidemiology of cancer in ataxia-telangiectasia. In: B. A. Bridges and D. G. Harnden (eds.), Ataxia-Telangiectasia: A Cellular and Molecular Link between Cancer, Neuropathology and Immune Deficiency, pp. 103-138. Chichester: John Wiley, 1982.
24. Swift, M., Reitnauer, P., Morrell, D., and Chase, C. Breast and other cancers in ataxia-telangiectasia families. N. Engl. J. Med., 316: 1289-1294, 1987.
25. Gianelli, F., Avery, J., Polani, P. E., Terrell, C., and Giammusso, V. Xeroderma pigmentosum and medulloblastoma: Chromosomal damage to lymphocytes during radiotherapy. Radiat. Res., 88: 194-208, 1981.